FDA planned to fast-track applications for authorization, but agency reviewers raise alarm over addiction risk ...
When granting licenses, the FDA weighs whether products can help smokers switch to a less harmful form of nicotine while not driving risks too high for non-tobacco users and children.
Popular nicotine pouch products like Zyn and Velo face delays in obtaining FDA authorisation in the U.S. due to concerns over ...
Nicotine pouches, most notably Zyn, have become very popular lately. While they've been sold in the U.S. for about a decade, demand has soared recently as fans spread the word online. Here's what you ...
Plans to fast-track sale of nicotine pouches in US stalls as FDA scientists fear impact on kids, report says - New versions ...
Philip Morris's stock surged over 41.50% in 2025, driven by the success of its innovative nicotine pouch product, Zyn, which received FDA marketing approval. British American Tobacco's VELO Plus, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results